Lori A. Leslie, MD, and Hoshiyuki Iida, APN, provide an overview of chronic lymphocytic leukemia and the risk stratification process. Lori A. Leslie, MD: Hello, and welcome to CURE Expert Connections® ...

In " Beyond Diagnosis: CLL," Cleveland Clinic hematologist/oncologist Allison Winter, MD, and host John Mangels explore how ...

Prevalence rates of chronic lymphocytic leukemia have steadily increased over the last 30 years, and are projected to continue to rise. Survival rates have steadily increased among all age groups ...

Genetic predisposition and lifestyle factors both play crucial roles in diabetes management and onset. Cancer treatment can complicate diabetes management, requiring careful coordination between ...

Although a single CLL-specific genomic aberration has not been identified, ≥80% of CLL cases do exhibit chromosomal abnormalities. 7 Four common genomic alterations exist and include aberrations on ...

Monoclonal B-cell lymphocytosis is when your body produces an elevated number of identical B cells. In some cases, it can develop into chronic lymphocytic leukemia. Monoclonal B-cell lymphocytosis ...

Most patients with chronic lymphocytic leukemia (CLL) have an indolent clinical course, but the disease remains incurable with standard therapy and the prognosis is dismal for those patients with ...

Share on Pinterest Researchers are hopeful a three-drug combination can be effective in the treatment of chronic lymphocytic leukemia. Phynart Studio/Getty Images Chronic lymphocytic leukemia can be ...

Abbreviations: BR, bendamustine plus rituximab; CLL, chronic lymphocytic leukemia; ECOG PS, Eastern Cooperative Oncology Group performance status; IGHV, immunoglobulin heavy-chain variable region; SLL ...

video: This spinning blue shape is the outer shell (glycoprotein) that shields lymphocytic choriomeningitis virus (LCMV) from immune system attack. And yet new research shows that an antibody (grey) ...